-

SHAREHOLDER ALERT: Robbins LLP Announces That Canoo Inc. (GOEV) is Being Sued for Misleading Shareholders

SAN DIEGO & TORRANCE, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Canoo Inc. (f/k/a Hennessy Capital Acquisition Corp. IV) (NASDAQ: GOEV, GOEVW) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between August 18, 2020 and March 29, 2021.

If you suffered a loss due to Canoo Inc.'s misconduct, click here.

Canoo Inc. (GOEV) Misled Investors Regarding its Business Model

According to the complaint, Canoo Holdings Ltd., an electric vehicle company, became a public entity via merger with Hennessy Capital, a special purchase acquisition company, on December 21, 2020. The companies announced the merger on August 18, 2020, filing its Registration Statement on Form S-1 with the SEC the same day. The Registration Statement touted Canoo's engineering and technology services, noting that "[t]his business offers a unique opportunity to generate immediate revenues in advance of the offering of our first vehicle and our current pipeline in this area is supportive of a projected $120 million of revenue in 2021." The Registration Statement noted that Canoo's "[c]ontract engineering services offer a separate revenue stream" and that its engineering services were considered a "positive factor" supporting the merger.

On March 29, 2021, after the market closed, Canoo revealed the Company would no longer focus on its engineering services line, which had been touted in the merger documents just three months earlier and formed the basis of Canoo's growth story. Discussions during the press conference also revealed that Canoo had decreased its focus on its plan to sell vehicles to consumers through a subscription model, and that contrary to prior statements Canoo did not have partnerships with original equipment manufacturers and no longer engaged in the previously announced partnership with Hyundai.

On this news, Canoo's stock price fell $2.50, or over 21%, to close at $9.30 per share on March 30, 2021.

If you purchased shares of Canoo Inc. (GOEV) between August 18, 2020 and March 29, 2021, you have until June 1, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Canoo Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Snowflake Inc. Class Action Reminder - Robbins LLP Encourages SNOW Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Snowflake Inc. (NYSE: SNOW) Class A common stock between June 27, 2023 and February 28, 2024. Snowflake is a software company that provides cloud data storage that enables customers to consolidate data onto data-driven applications and share data for the purpose of running analytics and other processes. For more information, submit a form, ema...

Corcept Therapeutics Incorporated Class Action Reminder – Robbins LLP Encourages CORT Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol.For more information, submit a...

uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period? September 24, 2025 – October 31, 2025What...
Back to Newsroom